He takes over from ThromboGenics’ Founder Prof Desire Collen, who is retiring from the position.
Staf Van Reet appointed as new Chairman of the Board at ThromboGenics
He takes over from ThromboGenics’ Founder Prof Desire Collen, who is retiring from the position.
Tags
Related posts
- Strong clinical data for Breye lead asset danegaptide
- EHP Awards triumph
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
